Mail

UK markets close in 7 hours 32 minutes

FTSE 100
8,289.04
+41.25(+0.50%)
FTSE 250
20,442.69
+79.26(+0.39%)
AIM
768.16
+0.13(+0.02%)
GBP/EUR
1.1841
+0.0004(+0.03%)
GBP/USD
1.2669
-0.0018(-0.14%)
Bitcoin GBP
48,699.71
+845.60(+1.77%)

The cost of following England at Euro 2024

What could your money earn if you invested your football spending elsewhere

Carl Zeiss Meditec AG (0DHC.IL)

IOB - IOB Delayed price. Currency in EUR

Add to watchlist

66.55

+0.55

(+0.83%)

As of 08:24AM BST. Market open.

Currency in EUR

Valuation measures⁴

Market cap (intra-day)	5.90B
Enterprise value	6.01B
Trailing P/E	22.53
Forward P/E	22.68
PEG ratio (5-yr expected)	3.02
Price/sales (ttm)	2.85
Price/book (mrq)	2.82
Enterprise value/revenue	2.92
Enterprise value/EBITDA	12.94

Trading information

Stock price history

Beta (5Y monthly)	0.90
52-week change ³	-31.54%
S&P500 52-week change ³	24.96%
52-week high ³	123.30
52-week low ³	62.50
50-day moving average ³	90.26
200-day moving average ³	94.93

Share statistics

Avg vol (3-month) ³	42.39k
Avg vol (10-day) ³	31.51k
Shares outstanding ⁵	89.44M
Implied shares outstanding ⁶	95.36M
Float ⁸	36.45M
% held by insiders ¹	59.14%
% held by institutions ¹	20.16%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	1.1
Forward annual dividend yield ⁴	1.42%
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	31.98%
Dividend date ³	N/A
Ex-dividend date ⁴	23 Mar 2023
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	30 Sept 2022
Most-recent quarter (mrq)	30 Jun 2023

Profitability

Profit margin	14.81%
Operating margin (ttm)	17.74%

Management effectiveness

Return on assets (ttm)	N/A
Return on equity (ttm)	N/A

Income statement

Revenue (ttm)	2.08B
Revenue per share (ttm)	23.20
Quarterly revenue growth (yoy)	12.10%
Gross profit (ttm)	1.13B
EBITDA	391.13M
Net income avi to common (ttm)	307.91M
Diluted EPS (ttm)	3.42
Quarterly earnings growth (yoy)	47.40%

Balance sheet

Total cash (mrq)	12.36M
Total cash per share (mrq)	0.14
Total debt (mrq)	156.75M
Total debt/equity (mrq)	7.92%
Current ratio (mrq)	N/A
Book value per share (mrq)	21.84

Cash flow statement

Operating cash flow (ttm)	N/A
Levered free cash flow (ttm)	N/A